Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Aehr Test Systems (NASDAQ: AEHR) closed at $15.17 in the last session, up 2.36% from day before closing price of $14.82. In other words, the price has increased by $2.36 from its previous closing price. On the day, 3.98 million shares were traded. AEHR stock price reached its highest trading level at $16.1656 during the session, while it also had its lowest trading level at $14.76.
Ratios:
We take a closer look at AEHR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.07 and its Current Ratio is at 5.71. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on July 17, 2024, Upgraded its rating to Buy and sets its target price to $25 from $12 previously.
On March 26, 2024, Craig Hallum Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 12 ’25 when SALAMONE ALBERTO bought 4,995 shares for $9.08 per share.
SALAMONE ALBERTO sold 4,995 shares of AEHR for $45,336 on May 12 ’25. The EVP, PPBI BUSINESS now owns 56,241 shares after completing the transaction at $9.08 per share. On Aug 02 ’24, another insider, SLAYEN HOWARD T, who serves as the Director of the company, bought 20,000 shares for $15.50 each. As a result, the insider paid 310,000 and bolstered with 220,714 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEHR now has a Market Capitalization of 451632128 and an Enterprise Value of 361973344. As of this moment, Aehr’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.55, and their Forward P/E ratio for the next fiscal year is 32.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.28. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.35 while its Price-to-Book (P/B) ratio in mrq is 3.64. Its current Enterprise Value per Revenue stands at 5.888 whereas that against EBITDA is 155.42.
Stock Price History:
The Beta on a monthly basis for AEHR is 2.34, which has changed by -0.014294982 over the last 52 weeks, in comparison to a change of 0.10500872 over the same period for the S&P500. Over the past 52 weeks, AEHR has reached a high of $21.44, while it has fallen to a 52-week low of $6.27. The 50-Day Moving Average of the stock is 43.23%, while the 200-Day Moving Average is calculated to be 32.20%.
Shares Statistics:
According to the various share statistics, AEHR traded on average about 858.26K shares per day over the past 3-months and 2032320 shares per day over the past 10 days. A total of 29.77M shares are outstanding, with a floating share count of 27.88M. Insiders hold about 6.36% of the company’s shares, while institutions hold 64.75% stake in the company. Shares short for AEHR as of 1749772800 were 6704496 with a Short Ratio of 7.81, compared to 1747267200 on 6935721. Therefore, it implies a Short% of Shares Outstanding of 6704496 and a Short% of Float of 23.709999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 2.0 analysts. The consensus estimate for the next quarter is $0.03, with high estimates of $0.03 and low estimates of $0.03.
Analysts are recommending an EPS of between $0.16 and $0.06 for the fiscal current year, implying an average EPS of $0.12. EPS for the following year is $0.22, with 3.0 analysts recommending between $0.28 and $0.15.
Revenue Estimates
According to 2 analysts, the current quarter’s revenue is expected to be $14.82M. It ranges from a high estimate of $15M to a low estimate of $14.65M. As of the current estimate, Aehr Test Systems’s year-ago sales were $16.6MFor the next quarter, 2 analysts are estimating revenue of $17M. There is a high estimate of $17M for the next quarter, whereas the lowest estimate is $17M.
A total of 3 analysts have provided revenue estimates for AEHR’s current fiscal year. The highest revenue estimate was $62.28M, while the lowest revenue estimate was $59.52M, resulting in an average revenue estimate of $60.57M. In the same quarter a year ago, actual revenue was $66.22MBased on 3 analysts’ estimates, the company’s revenue will be $74.03M in the next fiscal year. The high estimate is $75.77M and the low estimate is $71.9M.
